It has been proposed that knockdown of Notch1 signalling with a γ-secretase inhibitor can reverse glucocorticoid resistance in T-ALL [10], implicating Notch1 activation in chemoresistance. Here, NOTCH1 is linked to acute lymphoblastic leukemia.